Product Information
PRAMIPEXOLE ER 0.375 MG TABLET is a generic product labeled by Vitruvias Therapeutics Inc., priced at $0.9755 per EA under NDC 69680014530. Its NADAC has been published 196 times since Nov 23, 2022.
FDA first approved this application on Jun 11, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.375 mg/1
Manufacturer
Vitruvias Therapeutics Inc.NDC
69680014530
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PRAMIPEXOLE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212797FDA Approved
6/11/2021
TE Code
AB
On Market Since
8/27/2021
Pharmacological Classes
Price Statistics
The NADAC for PRAMIPEXOLE ER 0.375 MG TABLET has been published 196 times since Nov 23, 2022, and over the history we have for it it has declined 86.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9755 per EA |
|---|---|
| All-time high | $7.2200 (Jun 14, 2023) |
| All-time low | $0.9755 (Aug 19, 2026) |
| 52-week high | $1.7391 |
| 52-week low | $0.9755 |
| Median price | $3.1373 |
| Average price | $3.5919 |
| Largest weekly change | -45.6% (Nov 20, 2024) |
| Weeks tracked | 196 |
| Tracking since | Nov 23, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRAMIPEXOLE ER 0.375 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE ER 0.375 MG TABLET, manufactured by Vitruvias Therapeutics Inc., is $0.9755 per EA (NDC 69680014530), effective Aug 19, 2026.
How has the price of PRAMIPEXOLE ER 0.375 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRAMIPEXOLE ER 0.375 MG TABLET has declined 86.5%. It has been tracked across 196 weekly CMS publications since Nov 23, 2022.
What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE ER 0.375 MG TABLET?
Since Nov 23, 2022, the NADAC for PRAMIPEXOLE ER 0.375 MG TABLET has ranged from a low of $0.9755 (Aug 19, 2026) to a high of $7.2200 (Jun 14, 2023), with a median of $3.1373 per EA.
Are there cheaper alternatives to PRAMIPEXOLE ER 0.375 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAMIPEXOLE ER 0.375 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PRAMIPEXOLE ER 0.375 MG TABLET?
PRAMIPEXOLE ER 0.375 MG TABLET (NDC 69680014530) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.